ROYAL BANK OF CANADA - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 93 filers reported holding REGULUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$26,000
-73.7%
132,607
-11.8%
0.00%
Q2 2018$99,000
-6.6%
150,299
+2.5%
0.00%
Q1 2018$106,000
-7.0%
146,607
+33.8%
0.00%
Q4 2017$114,000
-37.7%
109,607
-25.2%
0.00%
Q3 2017$183,000
+0.5%
146,541
-20.4%
0.00%
Q2 2017$182,000
-32.6%
184,040
+12.1%
0.00%
Q1 2017$270,000
-27.8%
164,106
-1.2%
0.00%
Q4 2016$374,000
-43.6%
166,051
-17.4%
0.00%
Q3 2016$663,000
+3.0%
201,033
-9.7%
0.00%
Q2 2016$644,000
-58.1%
222,690
+0.3%
0.00%
-100.0%
Q1 2016$1,538,000
-15.9%
222,004
+5.8%
0.00%0.0%
Q4 2015$1,829,000
+43.3%
209,754
+7.4%
0.00%0.0%
Q3 2015$1,276,000
-43.4%
195,311
-5.1%
0.00%
-50.0%
Q2 2015$2,255,000
-31.3%
205,751
+6.1%
0.00%0.0%
Q1 2015$3,284,000
+41.9%
193,851
+34.4%
0.00%
+100.0%
Q4 2014$2,314,000
+241.3%
144,274
+45.4%
0.00%
Q3 2014$678,000
+0.4%
99,223
+18.2%
0.00%
Q2 2014$675,000
+58.1%
83,923
+77.4%
0.00%
Q1 2014$427,000
+379.8%
47,300
+294.2%
0.00%
Q4 2013$89,000
-21.2%
12,000
-0.1%
0.00%
Q3 2013$113,000
+91.5%
12,017
+100.3%
0.00%
Q2 2013$59,0006,0000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders